Indegene Stock Screener | Share Price & Fundamental Analysis
INDGN
Healthcare Technology
Share Price NSE
₹485.05
▼
-5.25 (-1.07%)
Share Price BSE
₹484.80
▼
-5.15 (-1.05%)
Track Indegene share price live with TickJournal's free stock screener.
Analyze Indegene share price history trends and compare 52-week high low
levels.
Calculate INDGN stock fair value using fundamental analysis and view live share price charts.
Determine Indegene share intrinsic value and compare it with current INDGN share price.
Record your Indegene trades in TickJournal's free trading journal and track your portfolio performance.
Indegene Market Cap
₹11,407.85 Cr.
INDGN P/E Ratio (TTM)
25.74
Indegene P/B Ratio
3.94
EPS (TTM)
₹17.15
Dividend Yield
0.42%
Debt to Equity
0.15
INDGN 52 Week High
₹619.70
Indegene 52 Week Low
₹464.85
Operating Margin
20.00%
Profit Margin
15.11%
INDGN Revenue (TTM)
₹781.00
EBITDA
₹173.00
Net Income
₹118.00
Total Assets
₹3,326.00
Total Equity
₹2,616.00
Indegene Share Price History - Stock Screener Chart
Screen INDGN historical share price movements with interactive charts. Analyze price trends and patterns.
Indegene Company Profile - Fundamental Screener
Screen Indegene company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for INDGN shares.
Indegene Limited is a global provider of digital-led commercialization services for the life sciences industry. The company offers solutions in analytics, technology, and commercial, medical, regulatory, and safety services to biopharmaceutical, emerging biotech, and medical devices companies. Indegene operates through four main segments: Enterprise Commercial Solutions, Omnichannel Activation, Enterprise Medical...more
Sector
Healthcare
Industry
Healthcare Technology
Sub-Sector
Healthcare Technology
Segment
E
Chairperson/CEO
Manish Gupta
ISIN
INE065X01017
Website
https://www.indegene.com
Indegene Balance Sheet Screener
Screen INDGN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 3,326 | 2,546 | 2,204 | 1,354 | 596 | 600 | 329 |
| Current Assets | 2,530 | 1,791 | 1,449 | 1,130 | 459 | 418 | 185 |
| Fixed Assets | 678 | 646 | 664 | 138 | 86 | 119 | 104 |
| Liabilities | |||||||
| Total Liabilities | 3,326 | 2,546 | 2,204 | 1,354 | 596 | 600 | 329 |
| Current Liabilities | 146 | 506 | 651 | 149 | 64 | 369 | 18 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 2,616 | 1,429 | 1,064 | 764 | 333 | -16 | 152 |
| Share Capital | 48 | 44 | 44 | 0 | 0 | 0 | 79 |
| Reserves & Surplus | 2,567 | 1,385 | 1,020 | 764 | 324 | -105 | 73 |
Indegene Income Statement Screener - Profit & Revenue Analysis
Screen Indegene income statement and profit fundamentals.
Analyze INDGN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Indegene share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 781 | 783 | 824 | 962 | 699 | 699 | 708 | 758 | 645 | 636 | 647 | 687 | 540 |
| Expenses | 608 | 606 | 664 | 783 | 534 | 548 | 561 | 589 | 535 | 511 | 515 | 525 | 413 |
| EBITDA | 173 | 177 | 160 | 179 | 164 | 151 | 148 | 170 | 111 | 125 | 133 | 162 | 127 |
| Operating Profit % | 20.00% | 20.00% | 17.00% | 17.00% | 21.00% | 19.00% | 18.00% | 18.00% | 15.00% | 16.00% | 19.00% | 22.00% | 21.00% |
| Depreciation | 21 | 22 | 23 | 40 | 19 | 20 | 19 | 20 | 20 | 20 | 20 | 18 | 10 |
| Interest | 3 | 4 | 4 | 5 | 12 | 12 | 4 | 3 | 12 | 13 | 12 | 12 | 2 |
| Profit Before Tax | 149 | 152 | 133 | 135 | 134 | 120 | 124 | 146 | 79 | 93 | 101 | 132 | 115 |
| Tax | 32 | 36 | 31 | 32 | 39 | 32 | 32 | 37 | 30 | 24 | 26 | 34 | 29 |
| Net Profit | 118 | 116 | 102 | 103 | 95 | 88 | 92 | 110 | 49 | 68 | 75 | 99 | 86 |
| EPS | 4.91 | 4.86 | 4.26 | 4.29 | 4.27 | 3.79 | 3.84 | 4.59 | 2.20 | 3.09 | 3.38 | 4.45 | 3.88 |
Indegene Cash Flow Screener - Liquidity Fundamentals
Screen INDGN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | 442 | 508 | 130 | 297 | 172 | 22 | 65 |
| Investing Activities | -677 | -327 | -896 | -158 | -81 | -16 | -18 |
| Financing Activities | 288 | -66 | 333 | 234 | -132 | 136 | -21 |
| Net Cash Flow | 52 | 115 | -433 | 373 | -41 | 143 | 25 |
Indegene Shareholding Pattern Screener
See Indegene shareholding pattern with promoter, FII, and DII holdings.
Check Indegene promoter holding and ownership changes for INDGN on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Apr | 2024-May | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| FII Holding | 5.24% | 10.05% | 11.30% | 11.48% | 3.56% | 0.00% | 0.00% | 3.79% |
| DII Holding | 4.96% | 7.20% | 6.96% | 8.07% | 5.33% | 0.00% | 0.00% | 3.84% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 11.34% | 13.51% | 13.28% | 12.45% | 11.38% | 0.00% | 0.00% | 24.67% |
| Other Holding | 78.45% | 69.24% | 68.46% | 68.00% | 79.73% | 100.00% | 100.00% | 67.70% |
| Shareholder Count | 144,708 | 151,997 | 151,809 | 147,182 | 443,785 | 82 | 82 | 203,599 |
Indegene Share Dividend Screener - Share Yield Analysis
Check Indegene dividend history with payout and yield data.
View Indegene dividend details including ex-dates and amounts for INDGN stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹2.00 | 0.42% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Indegene Stock Index Membership
See which indices include Indegene stock.
Check INDGN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Indegene Market Events Screener - Corporate Actions
Get Indegene corporate actions including splits, bonuses, and buybacks.
Check Indegene stock events that may affect INDGN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 9.73% | ||
| 2026-01-29 | 2026-01-29 | Quarterly Result Announcement | NA | -1.13% |
| 2025-10-30 | 2025-10-30 | Quarterly Result Announcement | NA | -1.67% |
| 2025-07-31 | 2025-07-31 | Quarterly Result Announcement | NA | -2.22% |
| 2025-06-26 | 2025-06-26 | Annual General Meeting | NA | -4.70% |
| 2025-06-13 | 2025-06-13 | Dividend | ₹ 2.00 /share | 5.49% |
| 2025-04-28 | 2025-04-28 | Quarterly Result Announcement | NA | -0.50% |
| 2025-01-30 | 2025-01-30 | Quarterly Result Announcement | NA | -6.18% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | 3.40% |
| 2022-11-17 | 2022-11-17 | Change Of Name | NA | - |
Indegene Competitors Screener - Peer Comparison
Screen INDGN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Syngene International | 17,502 | 50.99 | 3,714 | 3.77% | 496 | 16.84 |
| Indegene | 11,408 | 25.74 | 2,947 | 10.53% | 407 | 41.23 |
| Suven Life Sciences | 3,447 | -12.85 | 18 | -46.34% | -161 | 48.52 |
| Vimta Labs | 2,087 | 35.50 | 322 | 0.22% | 41 | 43.25 |
| Take Solutions | 723 | 14.98 | 10 | 126.67% | 1 | 75.14 |
| Bilcare | 151 | -3.53 | 807 | 4.78% | -56 | 36.94 |
| Jeevan Scientific Technology | 109 | -52.37 | 48 | 17.87% | 0 | 62.07 |
| Adeshwar Meditex | 30 | 33.09 | 84 | 5.00% | 2 | 25.68 |
| Vanta Bioscience | 14 | -1.06 | 2 | -78.57% | -13 | 14.41 |
Indegene Company Announcements - News Screener
Screen INDGN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-16 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-02-04 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2026-01-31 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-01-29 | Intimation Of Opening Of Trading Window | View |
| 2026-01-29 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2026-01-29 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | View |
| 2026-01-29 | Financial Results With Limited Review Report | View |
| 2026-01-29 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2026-01-29 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-01-29 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2026-01-29 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-01-23 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2026-01-23 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2026-01-22 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2026-01-22 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-22 | Board Meeting Intimation for The Consideration And Approval Of The Unaudited Consolidated And Standalone Financial Results Of The Company For The Quarter Ended December 31 2025 Along With The Limited Review Report Of The Auditors Thereon. | View |
| 2026-01-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2026-01-01 | Announcement under Regulation 30 (LODR)-Restructuring | View |
| 2025-12-31 | Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |